Bipartisan legislation that would launch an over-the-counter (OTC) user fee program coupled with monograph reform cleared the House Energy & Commerce health subcommittee Wednesday (Jan. 17) by voice vote, despite lawmakers grappling with a provision providing two years of exclusivity to innovative OTC drugs. The House draft -- authored by health subcommittee Vice Chair Brett Guthrie (R-KY), Chair Michael Burgess (R-TX) and ranking Democrat Gene Green (TX), as well as Reps. Bob Latta (R-OH), Diana DeGette (D-CO) and Debbie Dingell...